FindTrial
Sign In

To Understand The Effectiveness of Musta And Parpataka Kashaya In The Management Of Fever In Children

Evaluation Of Antipyretic Effect of Musta Parpataka Kashaya In Febrile Children-A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050797
Enrollment
30
Registered
2023-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R509- Fever, unspecified

Interventions

Intervention1: Musta and Parpat Kashaya: Dose - 15 ml - 48 ml Route of Administration - Oral Duration - once when there is Fever Control Intervention1: Paracetamol: Dose - 15mg/Kg/Dose Route - Oral

Sponsors

Shri BMK Ayurveda Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Those fulfilling diagnostic criteria

Exclusion criteria

Exclusion criteria: Any febrile condition of children requiring an immediate intervention depending on history and general condition at the point of examination as found by investigator will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Musta and Parpata kashaya may be effective in reducing Fever Timepoint: After administration of Medicine, for 1st hour - Once in 15 mins , Once in 30 mins for next 2 Hours—

Secondary

MeasureTime frame
Reduction in temperatureTimepoint: 3 hours—

Countries

India

Contacts

Public ContactDr ABHISHEK KUMAR SHUKLA

KAHER Shri BMK Ayurveda Mahavidyalaya

azizarbar.kaher@kleayurworld.edu.in9844532113

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026